Literature DB >> 10080950

Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.

C J Dimitroff1, P Pera, F Dall'Olio, K L Matta, E V Chandrasekaran, J T Lau, R J Bernacki.   

Abstract

Sialoglycans on the cell surface of human colon cancer (HCC) cells have been implicated in cellular adhesion and metastasis. To clarify the role of N-acetylneuraminic acid (NeuAc) linked alpha2,3 to galactose (Gal) on the surface of HCC cells, we studied the intercellular adhesion of HCC cell lines expressing increasing NeuAcalpha2,3Gal-R. Our model system consisted of the HCC SW48 cell line, which inherently possesses low levels of cell surface alpha2,3 and alpha2,6 sialoglycans. To generate SW48 clonal variants with elevated cell surface NeuAcalpha2,3Gal-R linkages, we transfected the expression vector, pcDNA3, containing either rat liver cDNA encoding Galbeta1,3(4)GlcNAc alpha2,3 sialyltransferase (ST3Gal III) or human placental cDNA encoding Galbeta1,3GalNAc/Galbeta1,4GlcNAc alpha2,3 sialyltransferase (ST3Gal IV) into SW48 cells. Selection of neomycin-resistant clones (600 microgram G418/ml) having a higher percentage of cells expressing NeuAcalpha2,3Gal-R (up to 85% positive Maackia amurenis agglutinin staining compared with 30% for wild type cells) was performed. These ST3Gal III and ST3Gal IV clonal variants demonstrated increased adherence to IL-1beta-activated human umbilical vein endothelial cells (HUVEC) (up to 90% adherent cells compared with 63% for wild type cells). Interestingly, ST3Gal III and ST3Gal IV clonal variants also bound non-activated HUVEC up to 4-fold more effectively than wild type cells. Cell surface NeuAcalpha2,3Gal-R expression within the various SW48 clonal variants correlated directly with increased adhesion to HUVEC (r=0.84). Using HCC HT-29 cells, which express high levels of surface NeuAcalpha2,3Gal-R, addition of synthetic sialyl, sulfo or GalNAc Lewis X structures were found to specifically inhibit intercellular adhesion. At 1.0mM, NeuAcalpha2,3Galbeta1,3(Fucalpha1, 4)GlcNAc-OH and Galbeta1,4(Fucalpha1,3)GlcNAcbeta1,6(SE-6Galbeta1++ +, 3)GalNAcalpha1-O-methyl inhibited HT-29 cell adhesion to IL-1beta-stimulated HUVEC by 100% and 68%, respectively. GalNAcbeta1, 4(Fucalpha1,3)GlcNAcbeta1-O-methyl and GalNAcbeta1,4(Fucalpha1, 3)GlcNAcbeta1,6Manalpha1,6Manbeta1-0-C30H61, however, did not possess inhibitory activity. In conclusion, these studies demonstrated that cell surface NeuAcalpha2,3Gal-R expression is involved in HCC cellular adhesion to HUVEC. These specific carbohydrate-mediated intercellular adhesive events may play an important role in tumor angiogenesis, metastasis and growth control. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10080950     DOI: 10.1006/bbrc.1999.0388

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model.

Authors:  Y Nemoto-Sasaki; M Mitsuki; M Morimoto-Tomita; A Maeda; M Tsuiji; T Irimura
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

3.  I-branched carbohydrates as emerging effectors of malignant progression.

Authors:  Charles J Dimitroff
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

4.  Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Authors:  Albert Lee; Joel M Chick; Daniel Kolarich; Paul A Haynes; Graham R Robertson; Maria Tsoli; Lucy Jankova; Stephen J Clarke; Nicolle H Packer; Mark S Baker
Journal:  Mol Cell Proteomics       Date:  2010-02-18       Impact factor: 5.911

Review 5.  Glycosylation at the fetomaternal interface: does the glycocode play a critical role in implantation?

Authors:  Carolyn J P Jones; John D Aplin
Journal:  Glycoconj J       Date:  2008-08-03       Impact factor: 2.916

6.  alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Authors:  Marta Pérez-Garay; Beatriz Arteta; Lluís Pagès; Rafael de Llorens; Carme de Bolòs; Fernando Vidal-Vanaclocha; Rosa Peracaula
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

7.  The structure of the oligosaccharides of N-cadherin from human melanoma cell lines.

Authors:  Dorota Ciołczyk-Wierzbicka; Angela Amoresano; Annarita Casbarra; Dorota Hoja-Łukowicz; Anna Lityńska; Piotr Laidler
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 8.  Leveraging fluorinated glucosamine action to boost antitumor immunity.

Authors:  Charles J Dimitroff
Journal:  Curr Opin Immunol       Date:  2012-12-06       Impact factor: 7.486

9.  Expression of the clustered NeuAcα2-3Galβ O-glycan determines the cell differentiation state of the cells.

Authors:  Kiyoshi Higashi; Kouji Asano; Masaki Yagi; Keita Yamada; Tatsuhiko Arakawa; Tomo Ehashi; Takashi Mori; Kayo Sumida; Masahiko Kushida; Satoshi Ando; Mitsuhiro Kinoshita; Kazuaki Kakehi; Taro Tachibana; Koichi Saito
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

10.  ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.

Authors:  Paula A Videira; Manuela Correia; Nadia Malagolini; Hélio J Crespo; Dário Ligeiro; Fernando M Calais; Helder Trindade; Fabio Dall'Olio
Journal:  BMC Cancer       Date:  2009-10-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.